Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

NCT: NCT05880810 · RECRUITING

NCT IDNCT05880810
StatusRECRUITING
Start Date2024-05-01
Completion2027-05
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).

Frequently Asked Questions

What is Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients?

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients is a clinical trial registered under NCT05880810. Current status: RECRUITING.

What is the status of NCT05880810?

The current status of NCT05880810 (Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients) is: RECRUITING.

When did Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients start?

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients started on 2024-05-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.